Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 08, 2025, titled "Strides Enters into a Strategic Product Development Partnership with Kenox to Expand Nasal Spray Portfolio for the US Market".
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Strides Pharma Science has announced a strategic product development partnership with Kenox to expand its nasal spray portfolio targeting the US market. The announcement was made via a press release dated September 08, 2025. The partnership is aimed at broadening Strides' presence in the US pharmaceutical space through collaborative development of nasal spray products. No financial terms, deal value, or revenue projections were disclosed in this filing.
This partnership signals Strides' continued push to grow its US specialty/generics footprint and could add future revenue streams once products are developed and approved. Short-term stock impact is likely limited since commercial timelines and financials are not specified.